Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

Tissue Antigens

Volumn 69, Issue 3, 2007, Pages 220-226

  Middleton, D ^a,b   Vilchez, J R ^c   Cabrera, T ^c   Meenagh, A ^a   Williams, F ^a   Halfpenny, I ^a   Maleno, I ^c   Ruiz Cabello, F ^c   Lopez Nevot, M A ^c   Garrido, F ^c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Human leucocyte antigen C group homozygosity; KIR genes; Tumour escape

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER TUMOR; COLORECTAL TUMOR; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; HETEROZYGOSITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; IMMUNOHISTOLOGY; KILLER IMMUNOGLOBULIN LIKE RECEPTOR GENE; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; HETEROZYGOTE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; URINARY BLADDER NEOPLASMS;

EID: 34247857425     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00792.x     Document Type: Article

References (25)

1. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Carbello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993 : 14 : 491 9.
2. Middleton D, Curran MD, Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002 : 10 : 147 64.
3. Middleton D, Williams F, Halfpenny IA. KIR genes. Transpl Immunol 2005 : 14 : 135 42.
4. Drenou B, Jacob MC, Accolla R et al. Quantification of HLA expression by flow cytometry. In : Charron D, ed. HLA: Genetic Diversity of HLA Functional and Medical Implication, Vol. I. 1997, 543 5.
5. Cabrera T, Angustias Fernandez M, Sierra A et al. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol 1996 : 50 : 127 34.
6. Cabrera T, Collado A, Fernandez MA et al. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens 1998 : 52 : 114 23.
7. Ramal LM, Maleno I, Cabrera T et al. Molecular strategies to define HLA haplotype loss in microdissected tumor cells. Hum Immunol 2000 : 61 : 1001 12.
8. Maleno I, Cabrera CM, Cabrera T et al. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Immunogenetics 2004 : 56 : 244 53.
9. Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002 : 60 : 254 8.
10. Parham P. MHC class molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005 : 5 : 201 14.
11. Middleton D, Meenagh A, Gourrard PA. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 2007 : 59 : 145 58.
12. Hsu KC, Liu X-R, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002 : 169 : 5118 29.
13. Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 2005 : 54 : 172 8.
14. Campillo JA, Martinez-Escribano JA, Muro M et al. HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis. Immunogenetics 2006 : 57 : 926 33.
15. Arnheim L, Dillner J, Sanjeevi CB. A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Tissue Antigens 2005 : 65 : 252 9.
16. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (KIR3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003 : 171 : 6640 9.
17. Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 2005 : 175 : 5222 9.
18. Carrington M, Wang S, Martin MP et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005 : 201 : 1069.
19. Dorothee G, Echchakir H, Le Maux Chansac B et al. Functional and molecular characterisation of a KIR3DL2/p140 expressing tumour-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. Oncogene 2003 : 22 : 7192 8.
20. Wechsler J, Bagot M, Nikolova M et al. Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes. J Pathol 2003 : 199 : 77 83.
21. Coca S, Perez-Pigueras J, Martinez D et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997 : 79 : 2320 8.
22. Sandel MH, Speetjens FM, Menon AG et al. Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol 2005 : 42 : 541 6.
23. Watson NF, Ramage JM, Madjd Z et al. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 2006 : 118 : 6 10.
24. Katz G, Gazit R, Arnon TI et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 2004 : 173 : 1819 25.
25. Velardi A, Ruggeri L, Moretta A, Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002 : 23 : 438 44.